BioCardia, Inc. 8-K

What Happened

• BioCardia, Inc. announced its financial results for the year ended December 31, 2025 in a press release dated March 24, 2026. The company furnished that press release as Exhibit 99.1 to a Form 8-K filed the same day (Item 2.02 — Results of Operations and Financial Condition).

Key Details

• Press release date: March 24, 2026.
• Fiscal period covered: Year ended December 31, 2025.
• Filing: Form 8-K, Item 2.02 (results of operations and financial condition).
• Exhibit furnished: 99.1 (press release); interactive XBRL cover page included as Exhibit 104.

Why It Matters

• The 8-K signals BioCardia has publicly reported its 2025 earnings and other year‑end financial metrics; investors should review the press release for details on revenue, net loss/profit, cash position, and any commentary on results or outlook.
• Because the 8-K itself only furnishes the press release, retail investors seeking actionable figures (earnings, revenue, guidance) should read Exhibit 99.1 or the company’s full SEC filings (10-K/10‑Q) for audited numbers and additional context.